In line with these findings, overexpression of HIF-1α conferred resistance to cetuximab-dependent apoptosis and inhibition of VEGF-A secretion in several cancer cells, whereas HIF-1α silencing restored the sensitivity to cetuximab, leading to antitumor responses [213]. The gene discussed is HIF1A; the disease is cancer.